Neurosteer Announces FDA Clearance of the Neurosteer EEG Brain Monitoring Platform

Nov 03, 2022

Neurosteer’s EEG System Features Novel Brain Activity Representation Based on Advanced EEG Signal Processing Technology

NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Neurosteer Inc. today announced the FDA clearance of its Neurosteer® single-channel EEG brain monitoring platform. This clearance allows Neurosteer’s unobtrusive multi-purpose system to be used in a broad range of clinical settings. In the ICU, it can offer continuous brain monitoring to support critical interventions. In a doctor’s office, it can aid in the early detection of pre-symptomatic cognitive decline, including Alzheimer’s, Parkinson’s and dementia. And in pharma drug trials, it can assist in the rapid and cost-effective massive screening of subjects who may be suffering from neurodegenerative disorders.

Neurosteer advances the century-old EEG into the 21st century, using an adhesive electrode strip connected to a pocket-sized sensor that wirelessly transmits EEG data to the cloud for advanced signal processing. Using just a single adhesive forehead strip, Neurosteer’s innovative solution offers the traditional EEG frequency bands while also being cleared by the FDA to include several novel “brain metrics” visual representations.

These brain metrics rely on Neurosteer’s advanced signal processing technology and may assist trained medical staff in making neurological diagnoses. In addition, affixing the adhesive strip to the forehead avoids interference from the hair, and using dry gel supports unattended operation for up to 12 hours. Finally, the system includes a noninvasive assessment with auditory prompts that can aid in the early detection of brain deterioration.

Dr. Amitai Bickel, Surgeon at Western Galilee Hospital, commented, “After working with the Neurosteer EEG system for several years, I’ve realized what an advantage it is to have a compact, easy-to-apply EEG brain monitor that can be used for real-time continuous monitoring. Neurosteer’s innovative platform has the potential to revolutionize the standard of care in managing brain health.”

Dr. Nathan Intrator, Founder and CEO of Neurosteer, said, “We are extremely pleased that the FDA has cleared our portable and affordable EEG system, and moreover, recognized the potential clinical value of our brain metrics visual representations. This is an important step in achieving our goal of making brain monitoring and assessment widely available to all populations.”

About the Company

Neurosteer Inc. has developed an innovative brain monitoring platform that is based on a portable single-channel EEG. It uses an adhesive forehead electrode strip connected to a pocket-sized sensor that wirelessly transmits EEG data to the cloud for advanced signal processing. It complements traditional frequency band analysis with “brain metrics” visual representations. The company was founded in 2015 by Dr. Nathan Intrator to commercialize brain monitoring technology that he initially developed at Tel Aviv University. With offices in New York, California and Israel, the company’s patented product is currently being validated in clinical trials and used by pharmaceutical companies for patient screening and efficacy testing of new drugs.

MORE INFO

< Older Post Newer Post >

Neurosteer’s Peer-Reviewed Publication: Evaluation of Parkinson’s Disease Early Diagnosis with Neurosteer’s hdrEEG™ System

19 Dec, 2023

Neurosteer Inc. announces the publication of our groundbreaking paper in Frontiers in Neurology detailing a revolutionary approach to Parkinson's disease detection and differentiation using our pocket-sized hdrEEG™ system and a rapid 15-minute auditory assessment.disorders.

Neurosteer to Present at ApplySci MIT

01 Sep, 2023

Neurosteer founder and CEO, Nathan Intrator PhD, has been invited to be a main speaker at the ApplySci AI + Deep Tech + NeuroTech conference at MIT later this month.

Brain Activity and Music as Seen with Neurosteer’s hdrEEG™ System

20 Jun, 2023

In “This Is What Music Does to Your Brain,” Yael Hallak of Haaretz writes that new research is exploring how to use music to bring people closer and even to diagnose cognitive decline in the elderly.

Neurosteer Delivers Real-Time Brain Monitoring to Peter Gabriel Reverberation Event

By Neurosteer • 23 Oct, 2022

Neurosteer participated in Peter Gabriel’s event at the Fotografiska Museum in NYC, demonstrating the effect of music and meditation on the brain using real-time graphics by displaying brain activity as it related to the intensity of focus, relaxation, and emotion.

Israeli Scientists Say Brain Analysis Tool Can Spot Cognitive Decline – Using Music

By Times of Israel • 26 Aug, 2022

A Tel Aviv University PhD student, Neta Maimon, came up with a 15-minute test that supports early detection of cognitive decline. The test uses musical cues in conjunction with Neurosteer’s EEG brain monitoring system to track brain function as elderly people listen to music.

Neurosteer Wins Roche Alzheimer’s Innovation Challenge

By Roche & Startup Nation Central • 14 Jul, 2022

Neurosteer was the winner of the Roche for a Better Future: Alzheimer’s Innovation Challenge , launched by Roche and Start-Up Nation Central with the vision of early detection and enhanced digital health support for Alzheimer’s disease patients and their caregivers.

Brain Health – Company of the Year Award

By Neurosteer • 15 Dec, 2019

Neurosteer received the “Brain Health Company of the Year” award from Tradex News . It has been a great year for us, most notably in improving our product for early screening of Alzheimer’s, Parkinson’s and fronto-temporal dementia.

The Effect of Music on Our Brain

By Neurosteer • 19 Nov, 2019

Following recent fMRI studies on the effect of music on the brain, Israeli TV Channel 13 interviewed Neta Maimon , a PhD student in music cognition at Tel Aviv University and a researcher at Neurosteer. Using Neurosteer sensing technology on a group of brain-monitored study participants, emotional and cognitive responses to songs were clearly visible.

Monitoring Two Runners During the NYC Marathon

By Neurosteer • 03 Nov, 2019

Neurosteer monitored two runners, in real time, during the NYC marathon on Nov 3rd. Prof. Steven Laureys, a key figure in the European Human Brain Project, was behind this initiative, which created significant interest in sports and other brain monitoring in extreme physical conditions. The article in DeMorgen describes it (in Dutch; use Google Translate). The full event was streamed live on Facebook . When going over the recording, one can see that Steven was meditating during much of the run (a well-known method to reduce oxygen consumption).

Monitoring and Assessing Surgeons at the ACS Conference

By Neurosteer • 30 Oct, 2019

Neurosteer, together with Stanford Prof. Carla Pugh, is quantifying and assessing surgeon performance before and during surgery as part of the Stanford Surgical Metrics project. During the American College of Surgeons conference in San Fransisco, brain activity data from more than 200 surgeons was collected. Check out the video to see the cognitive assessment and monitoring during simulated surgery. This illustrates an application of Neurosteer’s platform for the evaluation of cognitive performance of healthy subjects. The same setup can be used to monitor pilots and others during critical missions.